Society ❯ Health Equity

Access to Healthcare

Insurance Coverage Vaccination Access Community Health Patient Advocacy Rural Health Patient Care Community Health Programs Global Health Vaccine Access Vulnerable Populations Affordability Public Health Initiatives Vaccine Distribution Medication Affordability Healthcare Infrastructure Government Programs Prescription Drug Affordability Healthcare Services Healthcare Disparities Medication Access Prescription Medications Uninsured Patients Prescription Drug Access Chronic Conditions Political Influence Women's Health Health Services Elderly Care Healthcare Workforce Quality of Care Prescription Drug Costs Social Programs Cost of Medications Affordability of Medications Universal Health Coverage Medicaid Social Justice Insurance Affordability Cancer Care Women's Health Access Vaccination Policies Resource-Constrained Settings Affordable Healthcare Government Initiatives Immunization Developing Countries Uninsured Populations Financial Barriers Global Health Initiatives Preventative Healthcare Social Determinants of Health Underrepresented Populations Pricing Controversies Low-Income Countries Public Health Programs Community Health Services Mental Health Support Contraceptive Access Resource-Limited Settings Chronic Diseases Elderly Population Medicaid Recipients Support for Vulnerable Populations Private vs Public Healthcare Child Welfare HIV Treatment Two-Tier Healthcare System Diverse Communities Medical Supply Distribution Healthcare Logistics Community Services Reproductive Health Medical Services Healthcare Resources Vaccination Programs Public Health Policy Medical Resources Employment in Healthcare Telehealth Solutions Community Support Services Insurance Access Insurance Obligations Insurance Subsidies Affordable Care Financial Burden Barriers to Vaccination Aged Care Issues Healthcare Initiatives Socioeconomic Factors Impact of Drug Costs Universal Healthcare Insurance Accessibility Maternal Health Initiatives Telehealth Access Affordability of Treatments Impact of Privatization Chronic Disease Obesity Treatment Community Health Initiatives Public Health Rights

Democratic Report Puts TrumpRx Under Fresh Scrutiny as Analyses Question Real-World Savings

The new federal portal lists 43 brand-name drugs for cash buyers using manufacturer discounts negotiated under most‑favored‑nation terms.

TrumpRx Debuts With 43 Discounted Brand Drugs as Analyses Flag Cheaper Generics and Limits

WHO Seeks $1 Billion for 2026 Health Emergencies as Funding Shock Reshapes Agency

House Ways and Means Opens Probe of Two Hospitals Over Alleged Transplant Tourism

Trump Unveils Health Plan Focused on Direct Payments and Drug-Price Benchmarks

ACA Enhanced Subsidies Set to Expire Dec. 31 as House Prepares January Vote

White House Finalizes GLP-1 Price Deal With Lilly and Novo, Setting $50 Medicare Copays

California Pledges $140 Million, New York Adds $35 Million To Keep Planned Parenthood Clinics Operating

South Africa Sets April 2026 Rollout for Twice-Yearly HIV-Prevention Shot, With Limited Early Supply

Shutdown Lapse Halts Many Medicare Telehealth Visits as Hospitals Weigh Billing Risks

OTC Birth Control Tied to Major Uptake Gains in First Year, National Study Finds

CMS to Distribute $50B to Rural Hospitals and Launch $200B Medicaid Initiative

AI-Guided Home Neurostimulator Gains CE Approval, Targets Pilot Programs

WHO Endorses Twice-Yearly Lenacapavir Injections for HIV Prevention

Centene Withdraws 2025 Guidance Following $1.8 Billion Risk-Adjustment Shortfall

FDA Approves Yeztugo, Twice-Yearly HIV Prevention Injection